Search clinical trials for: Ado Trastuzumab Emtansine
Total 3582 results
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Jenny C. Chang, MDGenentech, Inc.; The Methodist Hospital Research InstituteWithdrawnBreast CancerUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | HER2 Positive Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
Spectrum Pharmaceuticals, IncTerminatedBreast CancerUnited States
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.Active, not recruitingBreast CancerUnited States, Canada, Spain, Belgium, China, Italy, Korea, Republic of, Taiwan, Australia, Japan, Brazil, France, Germany, United Kingdom, Hong Kong
-
Medstar Health Research InstituteGenentech, Inc.CompletedLeft Ventricular Function Systolic Dysfunction | HER2 Positive Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu PositiveUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.; Seagen Inc.RecruitingMetastatic Solid Tumor | Brain MetastasesUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.RecruitingLung Cancer | Bladder Cancer | Solid Tumor Cancers | Urinary Tract CancersUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Canada, Spain, France, Italy
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCActive, not recruiting
-
Western Regional Medical CenterTerminatedBreast Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Advanced CancerUnited States
-
Consorzio OncotechRoche Pharma AGRecruiting
-
Hoffmann-La RocheTerminatedGastric CancerUnited States, China, Korea, Republic of, Canada, Belgium, Brazil, Finland, Guatemala, Italy, Poland, Spain, Turkey, United Kingdom, Czechia, Hungary, Russian Federation, Argentina, France, Germany, Japan, Malaysia, Mexico, Panama, Peru, Philippin... and more
-
Genentech, Inc.Completed
-
Hoffmann-La RocheCompletedHER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast CancerIndia
-
Jules Bordet InstituteWithdrawnMetastatic HER2-positive Breast Cancer With Brain Metastasis
-
Hoffmann-La RocheCompleted
-
Genentech, Inc.Completed
-
Shanghai Miracogen Inc.RecruitingAdvanced Breast Cancer | Metastatic Breast CancerChina
-
Hoffmann-La RocheTerminatedMetastatic Breast CancerTaiwan, Korea, Republic of, Thailand, Malaysia
-
Tianjin Medical University Cancer Institute and...Not yet recruitingHER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
-
Hoffmann-La RocheCompletedBladder Cancer | Pancreas Cancer | Cholangiocellular CarcinomaSpain, Italy, Netherlands, Slovakia
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Italy, Korea, Republic of, Spain, Germany, Poland, Switzerland
-
Hoffmann-La RocheCompletedBreast CancerItaly, Belgium, Canada, United Kingdom, Argentina, Australia, Austria, Brazil, Bulgaria, China, Croatia, Denmark, Dominican Republic, Ecuador, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, Indonesia, Irelan... and more
-
Fondazione del Piemonte per l'OncologiaUnknown
-
Hoffmann-La RocheCompletedBreast CancerSpain, United States, France, Germany, Belgium, Korea, Republic of, Italy, Russian Federation
-
Hoffmann-La RocheTerminated
-
Hoffmann-La RocheNSABP Foundation Inc; German Breast GroupActive, not recruitingBreast CancerUnited States, Italy, United Kingdom, Canada, Czechia, Argentina, Austria, Belgium, Brazil, China, France, Germany, Guatemala, Ireland, Panama, Spain, Sweden, Taiwan, Turkey, Colombia, Hong Kong, Peru, Switzerland, South Africa, Israel, G... and more
-
xuexin heRecruitingHER2-positive Breast Cancer | Brain MetastasesChina
-
The Netherlands Cancer InstituteRoche Pharma AG; AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungNetherlands
-
Hoffmann-La RocheCompletedBreast CancerSpain, France, United States, United Kingdom
-
Fondazione del Piemonte per l'OncologiaUnknown
-
University of MiamiGenentech, Inc.TerminatedBreast Cancer | Metastatic Breast CancerUnited States
-
Swiss Group for Clinical Cancer ResearchCompletedMetastatic Breast CancerFrance, Switzerland, Netherlands, Germany
-
Cancer Trials IrelandTerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CancerIreland, Spain
-
Hoffmann-La RocheActive, not recruitingInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Croatia, Spain, Argentina, Mexico, Korea, Republic of, Bosnia and Herzegovina, Brazil, Costa Rica, Turkey, Singapore, Bulgaria, South Africa, India, Peru, Kenya, Chile
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
Genentech, Inc.Completed
-
National Cancer Institute (NCI)TerminatedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Hormone Receptor Negative Breast Cancer | HER2+ Breast CancerUnited States
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Germany, Spain, Taiwan, Australia, Canada, Italy
-
Genentech, Inc.Completed
-
Dana-Farber Cancer InstituteGenentech, Inc.Recruiting
-
MedSIRHoffmann-La RocheActive, not recruitingEarly Breast CancerSpain, Italy, Germany, Bulgaria, Hungary
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
N.N. Petrov National Medical Research Center of...RecruitingOligometastatic Disease | HER2-positive Metastatic Breast CancerRussian Federation
-
The First Affiliated Hospital with Nanjing Medical...RecruitingAdvanced Breast Cancer | Objective Response Rate | Trastuzumab EmtansineChina
-
Hoffmann-La RocheTerminatedBreast Cancer | Gastric CancerItaly, Argentina, Canada, France, Greece, Portugal, Slovakia, Brazil, Russian Federation, Spain, Germany, Serbia